|
1
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brandes AA, Tosoni A, Spagnolli F, Frezza
G, Leonardi M, Calbucci F and Franceschi E: Disease progression or
pseudoprogression after concomitant radiochemotherapy treatment:
Pitfalls in neurooncology. Neuro Oncol. 10:361–367. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ho VK, Reijneveld JC, Enting RH, Bienfait
HP, Robe P, Baumert BG and Visser O; Dutch Society for
Neuro-Oncology (LWNO), : Changing incidence and improved survival
of gliomas. Eur J Cancer. 50:2309–2318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kargbo RB: PROTAC degradation of IRAK4 for
the treatment of cancer. ACS Med Chem Lett. 10:1370–1371. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Q, Chen Y, Zhang D, Grossman J, Li L,
Khurana N, Jiang H, Grierson PM, Herndon J, DeNardo DG, et al:
IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in
colorectal cancer. JCI Insight. 4:e1308672019. View Article : Google Scholar
|
|
6
|
Cheng BY, Lau EY, Leung HW, Oi-Ning Leung
C, Ho NP, Gurung S, Cheng LK, Lin CH, Cheuk-Lam Lo R, Ma S, et al:
IRAK1 augments cancer stemness and drug resistance via the
AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma. Cancer
Res. 78:2332–2342. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang D, Li L, Jiang H, Knolhoff BL,
Lockhart AC, Wang-Gillam A, DeNardo DG, Ruzinova MB and Lim KH:
Constitutive IRAK4 activation underlies poor prognosis and
chemoresistance in pancreatic ductal adenocarcinoma. Clin Cancer
Res. 23:1748–1759. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Z, Wang Z, Zhang C, Liu X, Li G, Liu
S, Sun L, Liang J, Hu H, Liu Y, et al: Genetic and clinical
characterization of B7-H3 (CD276) expression and epigenetic
regulation in diffuse brain glioma. Cancer Sci. 109:2697–2705.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–77. 2015.PubMed/NCBI
|
|
10
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suzuki A, Horie T and Numabe Y:
Investigation of molecular biomarker candidates for diagnosis and
prognosis of chronic periodontitis by bioinformatics analysis of
pooled microarray gene expression datasets in gene expression
omnibus (GEO). BMC Oral Health. 19:522019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Grzmil M, Morin P Jr, Lino MM, Merlo A,
Frank S, Wang Y, Moncayo G and Hemmings BA: MAP kinase-interacting
kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human
glioblastoma. Cancer Res. 71:2392–2402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Griesinger AM, Birks DK, Donson AM, Amani
V, Hoffman LM, Waziri A, Wang M, Handler MH and Foreman NK:
Characterization of distinct immunophenotypes across pediatric
brain tumor types. J Immunol. 191:4880–4888. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Uhlen M, Zhang C, Lee S, Sjöstedt E,
Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z and Edfors F: A
pathology atlas of the human cancer transcriptome. Science.
357:eaan25072017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mootha VK, Lindgren CM, Eriksson KF,
Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E,
Ridderstråle M, Laurila E, et al: PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat Genet. 34:267–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang G, Bie F, Li G, Shi J, Zeng Y and Du
J: Study of the co-expression gene modules of non-small cell lung
cancer metastases. Cancer Biomark. Dec 3–2020.(Epub ahead of
print). doi: 10.3233/CBM-201605. View Article : Google Scholar
|
|
19
|
Li X, Liu Z, Mi M, Zhang C, Xiao Y, Liu X,
Wu G and Zhang L: Identification of hub genes and key pathways
associated with angioimmunoblastic T-cell lymphoma using weighted
gene co-expression network analysis. Cancer Manag Res.
11:5209–5220. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chan BKC: Data analysis using R
programming. Adv Exp Med Biol. 1082:47–122. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van Dam S, Vosa U, van der Graaf A, Franke
L and de Magalhães JP: Gene co-expression analysis for functional
classification and gene-disease predictions. Brief Bioinform.
19:575–592. 2018.PubMed/NCBI
|
|
22
|
Schwartzbaum JA, Fisher JL, Aldape KD and
Wrensch M: Epidemiology and molecular pathology of glioma. Nat Clin
Pract Neurol. 2:494–503. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Komori T: The 2016 WHO classification of
tumours of the central nervous system: The major points of
revision. Neurol Med Chir (Tokyo). 57:301–311. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen R, Smith-Cohn M, Cohen AL and Colman
H: Glioma subclassifications and their clinical significance.
Neurotherapeutics. 14:284–297. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Apte RS, Chen DS and Ferrara N: VEGF in
signaling and disease: Beyond discovery and development. Cell.
176:1248–1264. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yunker CK, Golembieski W, Lemke N, Schultz
CR, Cazacu S, Brodie C and Rempel SA: SPARC-Induced increase in
glioma matrix and decrease in vascularity are associated with
reduced VEGF expression and secretion. Int J Cancer. 122:2735–2743.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tu Y, Zhong Y, Fu J, Cao Y, Fu G, Tian X
and Wang B: Activation of JAK/STAT signal pathway predicts poor
prognosis of patients with gliomas. Med Oncol. 28:15–23. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang P, Chen FZ, Jia QB and Hu DF:
Upregulation of microRNA-133a and downregulation of connective
tissue growth factor suppress cell proliferation, migration, and
invasion in human glioma through the JAK/STAT signaling pathway.
IUBMB Life. 71:1857–1875. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumar DM, Patil V, Ramachandran B, Nila
MV, Dharmalingam K and Somasundaram K: Temozolomide-Modulated
glioma proteome: Role of interleukin-1 receptor-associated kinase-4
(IRAK4) in chemosensitivity. Proteomics. 13:2113–2124. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sloan KE, Stewart JK, Treloar AF, Matthews
RT and Jay DG: CD155/PVR enhances glioma cell dispersal by
regulating adhesion signaling and focal adhesion dynamics. Cancer
Res. 65:10930–10937. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng Y, Miu Y, Yang X, Yang X and Zhu M:
CCR7 Mediates TGF-beta1-induced human malignant glioma invasion,
migration, and epithelial-mesenchymal transition by activating
MMP2/9 through the nuclear factor KappaB signaling pathway. DNA
Cell Biol. 36:853–861. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luo J, Solimini NL and Elledge SJ:
Principles of cancer therapy: Oncogene and non-oncogene addiction.
Cell. 136:823–837. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Takada K, Kohashi K, Shimokawa M, Haro A,
Osoegawa A, Tagawa T, Seto T, Oda Y and Maehara Y: Co-Expression of
IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets
of novel combination therapy. Lung Cancer. 128:26–32. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guan X, Zhang C, Zhao J, Sun G, Song Q and
Jia W: CMTM6 overexpression is associated with molecular and
clinical characteristics of malignancy and predicts poor prognosis
in gliomas. EBioMedicine. 35:233–243. 2018. View Article : Google Scholar : PubMed/NCBI
|
